Jan 20, 2023:
https://thehill.com/policy/healthcare/3821657-ftc-asks-court-to-hold-pharma-bro-martin-shkreli-in-contempt
Mar 9, 2018:
https://www.usatoday.com/story/money/2018/03/09/martin-shkreli-sentenced-7-years-prison/359705002
Mar 5, 2018:
https://www.usatoday.com/story/money/2018/03/05/pharma-bro-martin-shkreli-forfeit-nearly-7-4-m-assets-he-faces-sentencing-foer-including-rare-wu-tan/396080002
Feb 28, 2018:
In a letter to Brooklyn federal court Judge Kiyo Matsumoto, Shkreli asked the judge for leniency.
'Pharma Bro' asks judge for leniency, saying he was a fool | The Seattle Times
Sep 14, 2017:
'Pharma Bro' Martin Shkreli Jailed at Tough Brooklyn Facility | NBC News
Aug 4, 2017:
After five days of deliberation a jury found Martin Shkreli guilty on three of the eight counts of fraud he was charged with.
Martin Shkreli Is Found Guilty of Fraud | The New York Times
Why 'Pharma Bro' Martin Shkreli Is Swaggering Into Jail | Bloomberg News
Jul 30, 2017:
Jury to Decide: Were Shkreli's Gambles to Save His Drug Company Criminal? | The New York Times
Jun 26, 2017:
The trial of Martin Shkreli begins today. Shkreli faces charges of securities fraud, wire fraud, and conspiracy for allegedly mismanaging investor money and running a Ponzi scheme with funds received by his investment companies Elea Capital, MSMB Capital, MSMB Healthcare, and while he was CEO of Retrophin, a pharmaceutical company he founded in 2011.
Martin Shkreli's fraud trial begins | CNN
Apr 19, 2017:
In Brooklyn, New York, U.S. District Court Judge Kiyo Matsumoto ruled that Shkreli will be tried separately from Evan Greebel.
Greebel is expected to testify that Shkreli lied to him. Shkreli is expected to testify that he acted based on the legal advice of Greebel.
Shkreli wins battle for separate trial in criminal securities fraud case | USA Today
Dec 17, 2015:
Martin Shkreli was arrested and indicted on charges of securities fraud and was freed on a $5 million bond. His lawyer, Evan Greebel, was also charged and was freed on a $1 million bond.
Shkreli, Drug Price Gouger, Denies Fraud and Posts Bail | Bloomberg News
Sep 20, 2015:
Turing Pharmaceuticals, a company founded by Martin Shkreli and of which he is the executive officer, raised the price of a drug named Daraprim from $13.50 a tablet to $750 a tablet. Daraprim is used to treat a life-threatening parasitic infection.
Regarding the price increase, Shkreli said the following:
This isn't the greedy drug company trying to gouge patients, it is us trying to stay in business...This is still one of the smallest pharmaceutical products in the world. It really doesn't make sense to get any criticism for this.
Source:
Pollack, Andrew. (September 20, 2015). "Drug Goes From $13.50 a Tablet to $750, Overnight". The New York Times. Retrieved 2017-07-23.
More: